Clinical trials in Namestovo

9 clinical trials in Namestovo, Slovakia. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in SlovakiaKlinickeSkusky.sk

Namestovo at a glance

clinical trials

Paediatric trials0
Research sites0

Quick filters

9 trials in Namestovo

Open in trial search

Type 2 diabetes mellitus

Recruiting

A study to assess the effect of elecoglipron alone and in combination with dapagliflozin on blood sugar control in adults with Type 2 diabetes

Registered drug

A study to assess the effect of elecoglipron alone and in combination with dapagliflozin on blood sugar control in adults with Type 2 diabetes

Registered drug

Slovakia

Participants:18–64 years · 65+ years
Substances:AZD5004
Sponsor:AstraZeneca AB

Contact Research Centre

Study on Baxdrostat and Dapagliflozin for Preventing Heart Failure in Patients at High Risk

Recruiting

Registered drug

Study on Baxdrostat and Dapagliflozin for Preventing Heart Failure in Patients at High Risk

Registered drug

Slovakia

Participants:18–64 years · 65+ years
Substances:Baxdrostat
Sponsor:AstraZeneca AB

Contact Research Centre

Type 2 diabetes mellitus+2

Not yet recruiting

Effect of lenbelintide (AZD6234) on body weight in adults with type 2 diabetes and obesity or overweight

Investigational

Effect of lenbelintide (AZD6234) on body weight in adults with type 2 diabetes and obesity or overweight

Investigational

Slovakia

Participants:18–64 years · 65+ years
Substances:AZD6234
Sponsor:AstraZeneca AB

Contact Research Centre

Arteriosclerosis

Not yet recruiting

Study of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)

Investigational

Study of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)

Investigational

Slovakia

Participants:18–64 years · 65+ years
Sponsor:Amgen Inc.

Contact Research Centre

Arteriosclerosis

Not recruiting

A study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)

Investigational

A study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)

Investigational

Slovakia

Participants:18–64 years · 65+ years
Sponsor:Amgen Inc.

Contact Research Centre

Hypercholesterolaemia

Not recruiting

Study of AZD0780 in patients with high cholesterol and heart disease or risk of heart disease to lower bad cholesterol levels

Investigational

Study of AZD0780 in patients with high cholesterol and heart disease or risk of heart disease to lower bad cholesterol levels

Investigational

Slovakia

Participants:18–64 years · 65+ years
Substances:Laroprovstat
Sponsor:AstraZeneca AB

Contact Research Centre

Arteriosclerosis

Not recruiting

Study of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease

Investigational

Study of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease

Investigational

Slovakia

Participants:18–64 years · 65+ years
Substances:Maridebart Cafraglutide
Sponsor:Amgen Inc.

Contact Research Centre

Dyslipidaemia

Not recruiting

Study of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke

Registered drug

Study of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke

Registered drug

Slovakia

Participants:18–64 years · 65+ years
Substances:Evolocumab
Sponsor:Amgen Inc.

Contact Research Centre

Atrial fibrillation+2

Not recruiting

Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

Registered drug

Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

Registered drug

Slovakia

Participants:18–64 years · 65+ years
Substances:Apixaban
Sponsor:Bayer AG

Contact Research Centre

Other cities in Slovakia

The busiest research cities in the country

All 92 cities in Slovakia

Clinical research in Namestovo

What the registry says about research in the country

01 Cardiovascular Health Studies

Clinical research focusing on heart failure prevention through combination therapy investigation. Studies evaluate the effectiveness of combining baxdrostat with dapagliflozin to reduce cardiovascular mortality risks.

Heart Failure Prevention
Cardiovascular Risk Management
Combination Therapy Assessment

These trials aim to advance our understanding of preventive treatments for heart conditions.

02 Stroke Prevention Research

Innovative studies examining stroke prevention in patients with atrial fibrillation. The research compares the efficacy of asundexian versus apixaban in preventing stroke and systemic embolism.

Atrial Fibrillation Management
Stroke Prevention Strategies
Bleeding Risk Assessment

Research focuses on developing safer and more effective anticoagulation treatments.

Back to Slovakia All countries